and the umbilical cord of a newborn. It comprises highly specialized cells, such as hematopoietic stem cells, endothelial progenitor cells and mesenchymal stem cells. Cord blood contains many immunologically distinct lineage cells that, if successfully transplanted, may have great therapeutic potential in the prevention and treatment of chronic diseases ranging from cancer to congenital conditions and immune deficiency.

Baylor Genetics, an affiliate of H.U. Group Holdings Inc. and the #1 NIH-funded genetics program at Baylor College of Medicine, has been a pioneer of precision medicine for over 40 years. Today, we offer a spectrum of clinically relevant genetic testing, infectious disease testing, access to world-renowned experts and the confidence to provide patients with the best care. Baylor Genetics is active in all 50 states of the US and 16 countries.

AlphaRose Therapeutics is a biotechnology company dedicated to developing life-changing medicines for children and families affected by rare genetic diseases. Our proprietary antisense oligonucleotide (ASO) platform uses next-generation chemistry designed for improved safety, and our AI-driven discovery engine has identified over 300 potential rare disease targets. Through RareLabs, our internal research platform, we compress the path from genetic diagnosis to proof-of-concept into approximately six months at a fraction of traditional costs — because families facing rare diseases cannot afford to wait. Our lead program targets Bain Syndrome, with additional programs in development for CDKL5 deficiency, prion disease, and Von Willebrand disease.

Our Story Clinion is an integrated eClinical Platform consisting of an Electronic Data Capture (EDC), Randomisation and Trial Supply Management (IWRS/RTSM), Patient Reported Outcomes (eCOA) and Clinical Trial Management Systems (CTMS). Clinion IT Services is a technology company offering innovative software solutions in the life sciences and pharmaceutical industries since 2010. Our first product, Clinion is an integrated clinical trial solution for small and medium CROs, academic research organizations and pharmaceutical companies.

Bone Solutions Inc. is a Dallas, Texas-based biotechnology and regenerative medicine company founded by Andrew Jonathan Hillman. The company develops and delivers biologics-based solutions for orthopedic and musculoskeletal conditions, with a focus on exosome therapy and advanced regenerative orthobiologics. Bone Solutions addresses conditions including degenerative disc disease, joint degeneration, and chronic musculoskeletal pain through evidence-based biologic treatments. The company operates under FDA-compliant biologics standards and is committed to advancing the clinical application of exosome-based therapeutics. Bone Solutions serves patients and healthcare providers seeking effective, minimally invasive alternatives to conventional surgical intervention for orthopedic conditions.

Baylor Genetics, an affiliate of H.U. Group Holdings Inc. and the #1 NIH-funded genetics program at Baylor College of Medicine, has been a pioneer of precision medicine for over 40 years. Today, we offer a spectrum of clinically relevant genetic testing, infectious disease testing, access to world-renowned experts and the confidence to provide patients with the best care. Baylor Genetics is active in all 50 states of the US and 16 countries. Baylor Miraca Genetics Laboratories is regulated under CLIA as qualified to perform high-complexity testing.  (CAP # 2109314 / CLIA # 45D0660090; Lab Director: Christine Eng, MD)

Origin Bio Solutions is an ecologically friendly microbial manufacturer and service company partnering with oil and gas operators to solve problems that arise from paraffin, H2S, scale, corrosion, asphaltenes, and oil spills on the earth's surface. Origin manufactures all of its microbes for either upstream, midstream, or downstream applications in the oil and gas industry for oilfield equipment or biological environmental oil remediation. Origin sells remediation products and H2S, paraffin, corrosion, scale and asphaltene products to multiple distributors including environmental remediation companies and chemical companies, or directly to oil and gas operating companies. Through years of research and development, Origin has developed sustainable solutions that eliminate the root causes of oil and gas production/refining issues, rather than masking the problems using chemicals and hot oil treatments. Origin uses custom-tailored microbial blends to replace costly O&G chemicals, hot oils, H2S scavengers, amine units, ultra-fabs, etc. Origin labs deliver unique processes that show measurable results for the control of H2s, paraffin, scale, corrosion, asphaltenes, and MIC.

Founded in early 2010 by Dr. Jeanette Hill, Spot On Sciences, an Austin, Texas based medical device company, is committed to the development and commercialization of biological sample collection devices that enhance patient safety and comfort while solving current sample collection, storage and stability problems. Initial development of the Spot On Cartridge is the HemaSpot blood collection and storage device (patent pending). Future development of the SpotOn Cartridge includes adaptation for collection of other biological fluids, including urine, saliva and tissue homogenate.

Curazene, LLC is a Biotechnology company committed to preserving and improving human life by providing SAFE and EFFECTIVE products to kill bacteria and eliminate skin irritants. Founded in 2010 we assembled a team of professionals with expertise in the medical, engineering, financial, manufacturing and nutritional industries, in addition to a wide range of managerial and successful entrepreneurial experience. Our Mission Our Mission at Curazene® is to earn your trust by providing SAFE, EFFECTIVE and simple health-care solutions. Our leadership team is attentive to social and scientific trends making major financial and operational decisions to ensure Curazene® remains a trusted company that delivers on what we promise: SAFE and EFFECTIVE products.